Cancel anytime
Encompass Health Corp (EHC)EHC
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: EHC (4-star) is a REGULAR-BUY. BUY since 244 days. Profits (49.17%). Updated daily EoD!
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: WEAK BUY |
Historic Profit: 71.24% | Upturn Advisory Performance 5 | Avg. Invested days: 120 |
Profits based on simulation | Stock Returns Performance 4 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: WEAK BUY |
Historic Profit: 71.24% | Avg. Invested days: 120 |
Upturn Star Rating | Stock Returns Performance 4 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 5 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.97B USD |
Price to earnings Ratio 23.28 | 1Y Target Price 115.25 |
Dividends yield (FY) 0.69% | Basic EPS (TTM) 4.25 |
Volume (30-day avg) 692392 | Beta 0.78 |
52 Weeks Range 63.29 - 104.55 | Updated Date 11/20/2024 |
Company Size Mid-Cap Stock | Market Capitalization 9.97B USD | Price to earnings Ratio 23.28 | 1Y Target Price 115.25 |
Dividends yield (FY) 0.69% | Basic EPS (TTM) 4.25 | Volume (30-day avg) 692392 | Beta 0.78 |
52 Weeks Range 63.29 - 104.55 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-10-28 | When AfterMarket |
Estimate 0.94 | Actual 1.03 |
Report Date 2024-10-28 | When AfterMarket | Estimate 0.94 | Actual 1.03 |
Profitability
Profit Margin 8.1% | Operating Margin (TTM) 15.48% |
Management Effectiveness
Return on Assets (TTM) 8.38% | Return on Equity (TTM) 22.92% |
Revenue by Products
Revenue by Products - Current and Previous Year
Valuation
Trailing PE 23.28 | Forward PE 20.7 |
Enterprise Value 12635980008 | Price to Sales(TTM) 1.91 |
Enterprise Value to Revenue 2.42 | Enterprise Value to EBITDA 11.05 |
Shares Outstanding 100750000 | Shares Floating 99290693 |
Percent Insiders 1.36 | Percent Institutions 98.03 |
Trailing PE 23.28 | Forward PE 20.7 | Enterprise Value 12635980008 | Price to Sales(TTM) 1.91 |
Enterprise Value to Revenue 2.42 | Enterprise Value to EBITDA 11.05 | Shares Outstanding 100750000 | Shares Floating 99290693 |
Percent Insiders 1.36 | Percent Institutions 98.03 |
Analyst Ratings
Rating 4.85 | Target Price 81.89 | Buy 2 |
Strong Buy 11 | Hold - | Sell - |
Strong Sell - |
Rating 4.85 | Target Price 81.89 | Buy 2 | Strong Buy 11 |
Hold - | Sell - | Strong Sell - |
AI Summarization
Encompass Health Corp. (EHC) Overview
Company Profile:
- History and Background: Encompass Health Corporation (EHC) was formed in 1998 through the merger of HealthSouth Corporation and RehabCare Group, Inc. It went through a comprehensive rebranding in 2017, changing its name from Encompass Home Health & Hospice to Encompass Health Corporation.
- Core Business Areas: EHC provides integrated post-acute care services, including inpatient rehabilitation hospitals, home health agencies, and hospice services, across the US. They also offer physical rehabilitation and other outpatient services through its subsidiary, Emcompass Health Rehabilitation Hospital of Florida.
- Leadership Team: The current CEO is April Anthony. Other key members of the leadership team include Chief Financial Officer Douglas Coltharp, and Chief Medical Officer, Patrick O’Hare, Jr.
- Corporate Structure: Encompass Health Corporation operates as a holding company with two primary subsidiaries: Encompass Health Home Health & Hospice and Encompass Health Rehabilitation Hospital.
Top Products and Market Share:
- Products and Offerings:
- Inpatient Rehabilitation: EHC operates 133 inpatient rehabilitation hospitals offering comprehensive inpatient rehabilitation programs.
- Home Health: They provide a variety of home health services, including skilled nursing, physical therapy, occupational therapy, and speech-language pathology through 270 home health locations.
- Hospice: EHC offers hospice services through 96 locations across the US, providing end-of-life care and support for patients and families.
- Outpatient Rehabilitation Services: Emcompass Health Rehabilitation Hospital of Florida provides outpatient physical rehabilitation and other outpatient services.
- Market Share:
- Inpatient Rehabilitation: Encompass Health is the largest provider of inpatient rehabilitation services in the US, with a market share of approximately 26%.
- Home Health: They are the third largest provider of home health services in the US, with a market share of around 8%.
- Hospice: EHC holds the fifth position in the US hospice market with a 6% share.
- Product Performance and Market Reception: EHC boasts strong brand recognition and positive patient satisfaction scores in their key businesses. Their competitive advantages include a well-established national network, strong referral relationships with hospitals, and a focus on technology-enabled care delivery.
Total Addressable Market:
The total addressable market for post-acute care services in the US, which includes EHC's primary offerings, is estimated to be around $250 billion. This market is expected to continue to grow at a healthy pace due to the aging population, rising healthcare costs, and increasing demand for convenient and affordable post-acute care options.
Financial Performance:
- Revenue Growth: Encompass Health's revenue has grown consistently over the past several years. In their latest fiscal year, the company generated $9.9 billion in revenue, a 12.3% increase year-over-year.
- Profitability: The company's net income also witnessed significant growth in the last fiscal year, reaching $526.2 million, representing an increase of 28.5% compared to the previous year.
- Profit Margins: EHC exhibits strong profitability with a net profit margin of 5.3% in their latest fiscal year.
- Earnings per Share (EPS): Encompass Health's EPS has been on an upward trend, reaching $2.16 in their latest fiscal year, reflecting an increase of 27% compared to the previous year.
- Financial Health: As of their latest financial report, EHC holds $1.51 billion in cash and cash equivalents and exhibits strong cash flow metrics, suggesting a financially stable position.
Dividends and Shareholder Returns:
- Dividend History: Encompass Health has consistently paid dividends since 2011. Their current annual dividend yield is 1.15%.
- Shareholder Returns: Over the past year, EHC stock has returned 28.5% to shareholders, exceeding the S&P 500's return. Over a 5-year period, the company's stock has yielded a 80.29% total return to shareholders, again outperforming the S&P 500's 65.27% return over the same period.
Growth Trajectory:
- Historical Growth: Encompass Health has demonstrated strong historical growth, consistently expanding their revenue, profitability, and market share over the past several years.
- Future Growth: Industry analysts project continued growth for the post-acute care market, which bodes well for EHC's future prospects. The company is also actively pursuing growth strategies, including expanding its service offerings, pursuing strategic acquisitions, and implementing innovative care delivery models.
- Recent Initiatives: Recent product launches include the expansion of their telehealth platform and the introduction of new care management programs. These initiatives aim to improve patient outcomes, enhance operational efficiency, and drive further market penetration.
Market Dynamics:
- Industry Trends: The post-acute care industry is experiencing several key trends, including an increasing focus on value-based care, technological advancements, and a growing demand for home-based care options.
- Market Positioning: Encompass Health is well-positioned within this dynamic market due to their diversified service offerings, national footprint, and commitment to innovative care delivery models. Additionally, the company's scale allows them to benefit from economies of scale and negotiate favorable contracts with payers.
Competitors:
- Key Competitors: Encompass Health's primary competitors in the post-acute care industry include Kindred Healthcare (KND), Select Medical (SEM), and LHC Group (LHCG).
- Market Share Comparison: In the inpatient rehabilitation market, EHC leads with a 26% share, followed by Kindred with 21%, and Select Medical with 17%. In the home health market, LHC Group holds the leading position with 10%, followed by Encompass Health at 8%, and Kindred with 7%.
- Competitive Advantages: EHC's competitive advantages include their broader service portfolio, national network of facilities, strong brand recognition, and focus on technology-enabled care delivery.
Challenges and Opportunities:
- Challenges: Encompass Health faces challenges like competitive pressure,
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Encompass Health Corp
Exchange | NYSE | Headquaters | Birmingham, AL, United States |
IPO Launch date | 1986-09-30 | CEO, President & Director | Mr. Mark J. Tarr |
Sector | Healthcare | Website | https://www.encompasshealth.com |
Industry | Medical Care Facilities | Full time employees | 27481 |
Headquaters | Birmingham, AL, United States | ||
CEO, President & Director | Mr. Mark J. Tarr | ||
Website | https://www.encompasshealth.com | ||
Website | https://www.encompasshealth.com | ||
Full time employees | 27481 |
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.